Tuesday, 20 April 2021


Most Popular
Pharma News
BioTech News
MedTech News
BioServices News
Video Gallery

Inside Magazine

BIG PHARMA RE-HASH MEDICAL MARIJUANA

Known to the world by many names, Marijuana, Cannabis, MJ, Pot, weed or Ganjika in Sanskrit and Ganja in Hindi, this ancient plant has been known to the ancient Indians and Chinese for its medicinal benefits. Ayurvedic texts known as Samhitas have extolled the many benefits of this widely available green wonder. Yet, due to misconceptions, willful or otherwise had shrouded it for many centuries. While there are numerous medicinal properties that can be applied, misuse of the plant could also have disastrous consequences, especially if used as an addictive derivative. The global medical cannabis market is set to reach $3.2 billion by 2025, according to GlobalData. With big pharma taking notice and interest in the sector, the cannabis industry is at the brink of a revolution. BioSpectrum deep dives in to the fascination of big pharma in the cannabis space, how will this disrupt the cannabis industry and most importantly how the pharmaceutical cannabis sector should be regulated?

  

For Feedback Email Us : communications@biospectrumasia.com

Click here to access E-magazine



BioSpectrum Infomercial